Korean J Anesthesiol.  1998 Sep;35(3):453-458. 10.4097/kjae.1998.35.3.453.

The Effects of the Loading Dose and Addition of Midazolam on the Involuntary Movement during Induction of Anesthesia with Propofol in Children

Affiliations
  • 1Department of Anesthesiology, College of Medicine, Ewha Womans University, Seoul, Korea.

Abstract

BACKGROUND
Spontaneous involuntary movements are a relatively common side effect during induction of anesthesia with propofol and related with the loading dose, especially in children. Midazolam has GABAergic effects that may modify propofol-induced involuntary movements. So the aims of this study was to determine the dose of propofol for induction without involuntary movements in unpremedicated children and to confirm that midazolam may interact with propofol to modify neuroexcitatory movements.
METHODS
Seventy two ASA physical status I, II children, between 4~13 yrs of age were included. The children were randomly assigned to group I (propofol 3 mg/kg), II (propofol 4 mg/kg), III (midazolam 0.1 mg/kg+propofol 3 mg/kg), or IV (midazolam 0.1 mg/kg+propofol 4 mg/kg). After the injection of propofol loading dose, an independent anesthesiologist graded the incidence, severity (grade 1~4), and duration of involuntary movements.
RESULTS
Spontaneous movements were described as excitatory, dystonic, and choreiform, with twisting, flexion, and extension of the arms and legs. The incidence of involuntary movements did not differ between groups. But the incidence of moderate to severe movements was higher in group II than any other group.
CONCLUSIONS
Intravenous midazolam 0.1 mg/kg failed to modify propofol-induced involuntary movements during induction of anesthesia with propofol loading dose 3 mg/kg and 4 mg/kg.

Keyword

Anesthetics, intravenous: propofol; Complication: involuntary movement

MeSH Terms

Anesthesia*
Arm
Child*
Dyskinesias*
GABA Agents
Humans
Incidence
Leg
Midazolam*
Propofol*
GABA Agents
Midazolam
Propofol
Full Text Links
  • KJAE
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr